id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0708-0009,FDA,FDA-1978-N-0708,"Answer from FDA to Pinecrest State School Dated August 7, 1979",Other,Letter(s),2014-09-24T04:00:00Z,2014,9,2014-09-24T04:00:00Z,,2014-09-24T13:51:17Z,,0,0,090000648057cb9c
FDA-1978-N-0708-0012,FDA,FDA-1978-N-0708,Withdrawal of  Certain Pre-1986 Proposed Rules; Final Action,Notice,Withdrawal,2014-09-24T04:00:00Z,2014,9,2014-09-24T04:00:00Z,,2014-09-24T14:02:52Z,56FR67440,0,0,090000648057cba5
FDA-1978-N-0708-0014,FDA,FDA-1978-N-0708,"Memorandum from FDA to DDM Dated April 17, 1979",Other,Memorandum,2014-09-24T04:00:00Z,2014,9,2014-09-24T04:00:00Z,,2014-09-24T14:22:15Z,,0,0,090000648185465c
FDA-1978-N-0708-0001,FDA,FDA-1978-N-0708,Regulatory Analysis Assessment for FDA's Proposal to Amend the Patient Labeling Requirements for Estrogenic Drug Products,Supporting & Related Material,Regulatory Analysis,2014-09-24T04:00:00Z,2014,9,,,2014-09-24T13:55:30Z,,0,0,090000648057cb35
FDA-1978-N-0708-0013,FDA,FDA-1978-N-0708,"Exhibits 1 through 14 RE: Memorandum from FDA to DDM dated April 17, 1979",Supporting & Related Material,Background Material,2014-09-24T04:00:00Z,2014,9,,,2014-09-24T14:23:58Z,,0,0,090000648185465a
FDA-1978-N-0708-0002,FDA,FDA-1978-N-0708,Requirement for Estrogens; Labeling Directed to the Patient,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2014-09-24T04:00:00Z,2014,9,2014-09-24T04:00:00Z,1979-06-19T03:59:59Z,2014-09-24T13:32:05Z,44FR22752,0,0,090000648057cb3e
FDA-1978-N-0708-0010,FDA,FDA-1978-N-0708,Withdrawal of Certain Pre-1986 Proposed Rules: Opportunity for Public Comment,Notice,Notice of Intent,2014-09-24T04:00:00Z,2014,9,2014-09-24T04:00:00Z,1991-10-29T04:59:59Z,2014-09-24T13:58:06Z,,0,0,090000648057cb9f